| |
| |
|
| Insider
Information: |
Mckinney Robert A |
| Relationship: |
Senior VP, CFO |
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
44,415 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$182,102 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,415 |
|
|
| Total
Value |
$182,102 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Senior VP, CFO |
2011-10-03 |
44,415 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-04-03 |
4 |
OE |
$21.77 |
$7,859 |
D/D |
361 |
17,571 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-06-20 |
4 |
AS |
$21.41 |
$64,239 |
D/D |
(3,000) |
14,244 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-07-03 |
4 |
OE |
$20.45 |
$46,874 |
D/D |
2,292 |
16,584 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-07-03 |
4 |
D |
$24.26 |
$50,364 |
D/D |
(2,076) |
14,508 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
22,508 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-10-02 |
4 |
OE |
$19.58 |
$9,203 |
D/D |
470 |
23,025 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-10-02 |
4 |
D |
$23.03 |
$9,857 |
D/D |
(428) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-10-27 |
4 |
AS |
$26.00 |
$104,000 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-10-27 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-01 |
4 |
AS |
$25.96 |
$103,856 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-01 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-10 |
4 |
AS |
$28.00 |
$112,000 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-10 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-13 |
4 |
AS |
$29.03 |
$116,124 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-13 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-27 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-11-27 |
4 |
AS |
$28.05 |
$112,188 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-12-11 |
4 |
AS |
$27.75 |
$110,988 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2006-12-11 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-03 |
4 |
D |
$26.66 |
$10,184 |
D/D |
(382) |
22,694 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-03 |
4 |
OE |
$4.00 |
$25,365 |
D/D |
4,428 |
23,076 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-03 |
4 |
AS |
$25.68 |
$102,708 |
D/D |
(4,000) |
22,597 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-16 |
4 |
AS |
$28.79 |
$115,160 |
D/D |
(4,000) |
22,694 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-16 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
26,694 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Financial Officer |
• – – |
2007-01-29 |
4 |
AS |
$29.72 |
$118,872 |
D/D |
(4,000) |
22,694 |
0 |
- |
|
96 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
